Summary of Ryvyl Inc. Special Meeting Company Overview - **Company**: Ryvyl Inc. (NasdaqCM: RVYL) - **Event**: Special Meeting of Stockholders - **Date**: March 18, 2026 Key Points Merger Proposal - The primary agenda of the meeting was to vote on a proposed merger transaction with RTB Digital, Inc. and related matters as outlined in the definitive proxy statement filed with the SEC [2][6] - The merger agreement was dated September 28, 2025, and had been amended [7] Voting Results - As of the meeting, approximately 43% of the shares entitled to vote had been cast, which did not meet the required 50% plus one vote for approval of the merger [6] - Among the votes cast, approximately 99% were in favor of the merger [7] Meeting Adjournment - Due to the insufficient votes for approval, the meeting was adjourned to allow additional time for shareholders to submit their votes [7] - The meeting will remain open until March 25, 2026, at 4:00 PM Eastern Time [8] Shareholder Participation - The record date for eligible voters was set as February 6, 2026, with a total of 1,266,631 shares of common stock and 50,000 shares of Series C preferred stock outstanding [5] - The Series C preferred stock was entitled to vote equivalent to 205,775 shares [5] Management and Board Involvement - George Oliva served as the Interim CEO, CFO, and Director, leading the meeting [2] - Other board members present included Brett Moyer, Gene Jones, and Todd Browndorf, each serving on various committees [3] Communication and Transparency - The company committed to filing a press release and a current report on Form 8-K with the SEC to announce the new meeting date and time [8] - Shareholders were instructed on how to change their votes and attend the virtual meeting [8] Additional Notes - The meeting was conducted virtually to facilitate global participation [2] - The presence of outside counsel and an election inspector was noted, ensuring compliance with corporate law and SEC requirements [4]

Ducommun (NYSE:DCO) Conference Call Summary Company Overview - **Company Name**: Ducommun - **Industry**: Aerospace and Defense - **History**: Oldest continuously operating company in California, evolved from a general store to a provider of engineered products for aerospace and defense over 177 years [2][3] Financial Performance - **Market Capitalization**: Increased by almost 400% as of the end of last year, with further growth noted in early 2026 [4] - **Revenue Growth**: Achieved a 50% increase in revenues despite a downturn in commercial aerospace due to the pandemic [4] - **EBITDA Growth**: Increased by 144%, with a margin expansion of 600 basis points under current management [5] Business Segmentation - **Revenue Composition**: - 58% from defense - 38% from commercial aerospace - 4% from niche industrial exposure [5] - **Key Platforms**: Focus on narrow-body platforms (e.g., 737 MAX, A220, A320) and some wide-body exposure (e.g., 787) [6] Strategic Initiatives - **Vision 2027 Strategy**: A five-year plan aiming to grow revenue from approximately $700 million in 2022 to $950 million-$1 billion by 2027, with a target margin expansion from 13% to 18% [10] - **Margin Expansion**: Achieved 340 basis points of margin expansion, primarily through improvements in gross margin, disciplined pricing, and cost management [11][12] Engineered Products Focus - **Engineered Products Growth**: Increased from 15% to 23% of revenue, with a target of over 25% by the end of next year [13] - **Acquisitions**: Completed five acquisitions in the last 8-9 years, focusing on businesses with engineered product attributes [14] Defense Sector Insights - **Defense Business Growth**: - Missiles business grew by 20% in 2025 - Radar business grew by over 30% in 2025 - Overall defense business grew by 14% [16][22] - **Key Programs**: Positioned on critical missile programs identified by the Department of Defense, with long-term agreements in place to ramp up production [24] Manufacturing Capabilities - **Niche Manufacturing**: Capabilities include ruggedized interconnects, circuit card assemblies, and titanium hot forming parts, allowing for decent margins even without design IP [18] - **Capacity for Growth**: Existing capacity allows for significant growth in both commercial aerospace and defense sectors [30] Competitive Landscape - **Market Position**: Sole source for many engineered products, ensuring long-term contracts once specced in [42] - **Competitors**: Diverse competitors across different product lines, including subsidiaries of larger firms like TransDigm and HEICO [42] M&A Strategy - **Acquisition Focus**: Targeting engineered product businesses within aerospace and defense, avoiding industrial companies [46] - **Leverage Management**: Current management has successfully reduced leverage over the past 8-9 years, with a willingness to maintain conservative leverage levels [46][49] Future Outlook - **Investor Day**: Planned for September 17, where the next five-year plan will be announced, building on the progress made towards Vision 2027 [25][26] - **Growth Potential**: Strong positioning in both defense and commercial aerospace sectors, with expectations for continued growth driven by geopolitical events and increased production needs [22][24] This summary encapsulates the key points from the Ducommun conference call, highlighting the company's strategic direction, financial performance, and market positioning within the aerospace and defense industry.

Powell Industries Conference Call Summary Company Overview - **Company Name**: Powell Industries (NasdaqGS:POWL) - **Industry**: Electrical technology and solutions manufacturing - **Founded**: 1947 - **Headquarters**: Houston, Texas - **Revenue**: Just over $1 billion [2][3] Key Points Business Model and Product Offerings - Powell Industries manufactures electrical technology that controls power flow across various sectors, including industrial, utility, and commercial markets [3][5] - The company operates seven manufacturing facilities in the U.S. and Canada, primarily adhering to ANSI standards, with one facility in the UK supporting IEC standards [3][4][12] - Product range includes medium voltage breakers, switchgear, and modular substations, with a focus on low to medium voltage solutions (480 volts to 38,000 volts) [6][8][10] Market Segmentation - Revenue is primarily derived from three segments: industrial (oil and gas, petrochemicals), utility (growing segment), and commercial (including data centers) [18][19] - The company has seen a strategic shift, with electric utility now representing about 30% of the backlog, up from 21% in 2021 [28][29] Financial Performance - Significant growth in financial metrics over the past five years, with gross profit margins increasing from approximately 16% in 2021 to nearly 30% in 2025 [24] - EBITDA margins improved from 2.5% to 20.4% during the same period [24] - Record backlog of $1.6 billion, driven by large orders, including a $100 million LNG order and a $75 million data center order [26][27] Capital Allocation and Strategy - The company maintains a healthy cash balance of $500 million, with plans for strategic investments in R&D and capacity expansion [21][22] - Recent tuck-in acquisition of Remsdaq aimed at enhancing digital automation capabilities [16][21] - Ongoing capacity expansions, including a 50,000 sq ft addition to the breaker factory and a new offshore yard to support large industrial projects [32][33] Competitive Landscape - Competes with major players like ABB, Eaton, Schneider, and Siemens, focusing on execution and customer relationships to differentiate [19][45] - Emphasizes a front-end project management model that fosters long-term client relationships [45][46] Industry Trends and Challenges - The company is monitoring commodity prices, particularly copper, and has a hedging program in place [37] - Elevated oil prices may positively impact order volumes in the future, particularly in the gas market [42][43] - Powell is exploring opportunities to expand into IEC markets while maintaining its ANSI focus [36] Future Outlook - Powell aims to be the preferred electrical solutions provider for energy distribution, with a focus on safety and digital management of energy solutions [19][20] - The company is optimistic about growth prospects in the commercial sector, particularly data centers, and plans to leverage its competitive advantages in the market [46][47] Additional Insights - Powell is the last publicly traded company in its niche, manufacturing breakers and switchgear domestically, which aligns with government incentives for "Buy America" initiatives [47]

Summary of Global Industrial Company Conference Call Company Overview - **Company Name**: Global Industrial Company (NYSE:GIC) - **Headquarters**: Port Washington, New York - **Revenue**: $1.38 billion in 2025 - **Employees**: Approximately 1,900+ across the U.S., Canada, and globally - **Industry Ranking**: Ranked 18th by Industrial Distribution's Big 50 List - **Core Business**: Leading industrial distributor specializing in big and bulky products requiring LTL deliveries [2][3] Core Points and Arguments - **Customer-Centric Strategy**: The company is transforming into a more customer-centric organization, focusing on personalized experiences and specialized solutions to enhance customer satisfaction and drive growth [5][12] - **Market Position**: Global Industrial operates in a highly fragmented market with over 4,000 distributors in North America, maintaining a diversified customer base with no single customer exceeding 2% of sales [6][8] - **Private Label Products**: Private label brands account for approximately 40% of revenue, offering a margin premium of 15%-20%. This segment is considered a core competency and a point of differentiation [9][42] - **Financial Health**: The company has a debt-free balance sheet, generating excellent free cash flow, and a cash conversion ratio of 1.1x in 2025 [16][17] - **Growth Strategy**: Plans to expand through organic growth and M&A, focusing on strategic acquisitions that complement existing operations and enhance market share [17][28] Industry Dynamics - **Market Trends**: The company is well-positioned to navigate industry trends, including the acceleration of e-commerce and elevated B2B customer expectations [11][12] - **Manufacturing Sector**: The manufacturing sector is the largest end market for Global Industrial, providing a significant growth opportunity as the manufacturing PMI shows signs of expansion [31][32] - **Tariff Impact**: The company is managing pricing strategies in response to tariffs and market disruptions, with a focus on maintaining margins while capturing volume growth [33][35] Additional Insights - **AI and Automation**: The company is in the early stages of deploying AI and automation to enhance operations, including pricing analytics and customer service [26][27] - **Sales Strategy**: A multi-pronged go-to-market strategy is being implemented, with a focus on e-commerce and expanding outside sales teams to capture new customers [13][14] - **Community Engagement**: The company emphasizes community involvement, exemplified by partnerships with local nonprofits to educate students about career opportunities [4] Conclusion - Global Industrial Company is focused on enhancing its customer-centric approach, expanding its product offerings, and leveraging its strong financial position to drive growth. The company is optimistic about its future performance, aiming to build on the successes of 2025 and navigate the evolving market landscape effectively [18][56]

Summary of Federal Reserve System Update - March 18, 2026 Industry Overview - **Industry**: U.S. Economy and Monetary Policy - **Key Focus**: Federal Reserve's dual mandate of maximum employment and stable prices Core Points and Arguments 1. **Economic Growth**: The U.S. economy is expanding at a solid pace, with real GDP projected to rise by 2.4% in 2026 and 2.3% in 2027, which is stronger than previous projections [2][4] 2. **Labor Market**: The unemployment rate remains stable at 4.4%, with low job gains attributed to a decline in labor force growth due to lower immigration and participation [2][3] 3. **Inflation Trends**: - Total PCE prices rose by 2.8% over the past year, with core PCE prices increasing by 3.0% [3] - Inflation expectations have risen recently due to higher oil prices from Middle East supply disruptions [3][5] 4. **Monetary Policy Stance**: The Federal Reserve decided to maintain the federal funds rate target range at 3.5%-3.75%, viewing this as appropriate to support employment and control inflation [4][5] 5. **Future Projections**: - The median projection for the federal funds rate is 3.4% by the end of 2026 and 3.1% by the end of 2027, unchanged from previous estimates [5] - The Fed is prepared to adjust its policy based on incoming data and evolving economic conditions [5][6] Important but Overlooked Content 1. **Impact of Oil Prices**: Higher energy prices are expected to push up overall inflation, but the duration and extent of this impact remain uncertain [5][6] 2. **Consumer Spending**: There are concerns that rising gas prices could divert consumer spending from other areas, potentially impacting overall economic growth [15][17] 3. **Historical Context**: The Fed is cautious about the long-term effects of repeated supply shocks (tariffs, COVID-19, oil price shocks) on inflation expectations and economic stability [48][49] 4. **Stagflation Concerns**: The Fed does not currently view the situation as stagflation, as unemployment remains close to normal levels despite inflation being above target [62][63] 5. **Communication Strategy**: The Fed has not made significant changes to its communication strategies, reflecting a lack of broad support for new ideas among committee members [51][80] Conclusion The Federal Reserve remains focused on balancing its dual mandate amid a complex economic landscape characterized by stable growth, persistent inflation, and external shocks. The outlook for inflation and employment will continue to guide monetary policy decisions in the coming months.

Summary of Forum Markets Incorporated Conference Call Company Overview - **Company**: Forum Markets Incorporated (NasdaqCM:ETHZ) - **Business Model**: Focuses on acquiring real-world assets in large verticals, tokenizing them on the regulated financial institution Liquidity.io, and generating revenue through yield and cash flows from these assets [1][5][4] Key Points Business Strategy - **Tokenization**: The company is tokenizing assets such as CFM56 jet engines, which are on long-term contracts with major U.S. airlines, to distribute returns to token holders [2][10] - **Management Team**: The management team has extensive experience in aerospace, defense, and private equity, with a board that is actively involved in capital sourcing and deal connectivity [3][4] Financial Position - **Assets**: The company currently holds over $100 million in assets, including equity stakes in acquired businesses and cash-generating assets [5][7] - **Revenue Generation**: Revenue is primarily generated from holding cash-flowing assets, token origination fees, and asset management fees [20][45] Market Position - **Tokenization Market**: The company believes it is at the forefront of the tokenization market, which is still in its early stages. It aims to create a marketplace for tokenized real-world assets [21][22] - **Verticals**: The company is focusing on three main verticals: car loans, modular home loans, and aerospace, with plans to expand into commercial real estate [23][29][30] Future Plans - **Expansion**: Plans to increase capital allocation into cash-flowing assets, targeting over $100 million deployed by summer [41] - **Token Development**: Upcoming tokens include a Zippie token for modular home loans, expected to yield 9%-11% [28][29] Regulatory Environment - **Compliance**: The company is following U.S. securities regulations for token offerings and believes that a strict regulatory framework will benefit the marketplace [39] Market Dynamics - **Competition**: While there are discussions about tokenization, the company claims to be unique in its approach to tokenizing specific asset types at the level it is currently doing [43] Stock Performance - **Stock Valuation**: The stock price has been affected by the decline in Ethereum, which constituted a significant part of the balance sheet. The company is gradually reducing its Ethereum exposure [32][33] Distribution Strategy - **Token Marketing**: The company has not aggressively marketed its tokens yet, focusing instead on ensuring the functionality of the Liquidity platform before expanding distribution efforts [35][36] Additional Insights - **Yield Characteristics**: The token structure allows investors to receive direct collateral and cash flow from the assets, with unique tax benefits expected for future offerings [14][15] - **Operational Efficiency**: The use of blockchain technology is aimed at improving efficiency in asset origination and cash flow distribution [4][5][25] This summary encapsulates the key aspects of Forum Markets Incorporated's conference call, highlighting its business model, financial position, market strategy, and future plans.

Repligen Conference Call Summary Company Overview - **Company**: Repligen (NasdaqGS:RGEN) - **Industry**: Bioprocessing and Life Sciences Key Points Company Positioning and Strategy - Repligen has a unique and broad product offering, with a strong focus on innovation, which is central to its strategy [2][3] - The company has successfully engaged with large pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to showcase its extensive product portfolio [10] Product Differentiation - Approximately 80% of Repligen's portfolio is differentiated, focusing on unmet customer needs [4] - Key products include: - **ATF (Alternating Tangential Flow)**: Developed to enhance process intensification, allowing more output from the same footprint [4] - **Pre-packed Columns**: Addressing the challenge of finding skilled labor for column packing, providing a competitive advantage [5] - The remaining 20% of the portfolio focuses on customer-centric services, improving lead times and customer service [6] Customer Engagement and Market Growth - Visibility with major pharmaceutical accounts has significantly improved over the past 2.5 years, with a 2.5x increase in product lines sold to large accounts [10] - Repligen is now involved in 80-90% of major RFPs for bioprocessing equipment, indicating strong market presence [12] - The company is packaging technologies into full workflow solutions for specific customer needs, enhancing its value proposition [11] Financial Performance and Guidance - Repligen's guidance for 2026 is similar to the previous year's guidance, reflecting confidence in continued growth despite market headwinds [19][52] - The company aims for a 30% EBITDA margin and 25% EBIT margin by 2030, with a focus on price capture, volume leverage, and manufacturing productivity [27][28] - In 2025, Repligen achieved a 240 basis point expansion in EBIT margin, with a target of 150 basis points for 2026 [29] Market Dynamics and Competitive Landscape - The bioprocessing market is characterized by a significant portion of sales coming from consumables (75-80%), with equipment sales being more prominent during the initial setup of new facilities [16] - Repligen collaborates with competitors like Sartorius on certain technologies while maintaining a distinct market position [17][18] Innovation and Product Development - The company is focused on developing custom resins and ligands, significantly reducing development time compared to competitors [41][42] - Repligen is enhancing its process analytics portfolio through mergers and technology integration, aiming to lead in AI-enabled bioprocessing solutions [45][49] Future Outlook - Repligen anticipates a growth acceleration starting in 2027, driven by increased CapEx spending and improved FDA approval rates for biologics [55][56] - The company is optimistic about the future of bioprocessing, expecting several years of growth as market conditions improve [60] Additional Insights - The importance of talent acquisition in the bioprocessing industry is emphasized, with Repligen successfully attracting experienced professionals [36][37] - The company is actively monitoring regulatory changes and market dynamics that could impact growth and investment strategies [56][60]

Summary of Carrier's Q1 2026 Earnings Call Company Overview - **Company**: Carrier - **CEO**: David Gitlin - **Focus**: Intelligent climate and energy solutions, with a strong emphasis on electrification, energy efficiency, digitalization, and data center growth [4][5] Key Industry Insights - **Sector**: Industrial sector, specifically HVAC and energy solutions - **Market Trends**: Strong demand in commercial HVAC and data centers, with a notable 400% increase in data center orders in Q4 [5][11] Financial Performance - **Sales Guidance**: Projected sales of approximately $5 billion for Q1 and $5.6 billion for Q2, reaffirming annual guidance [13][14] - **Growth Metrics**: 40% of the portfolio has seen double-digit growth over the past five years, with expectations for continued growth [5][7] Product Innovations - **New Products**: Introduction of integrated heat pumps, dual fuel rooftop units, and advanced chillers, enhancing market share and margins [6][7] - **Chiller Capacity**: Significant expansion in chiller capacity, with a 3-4x increase in North America, allowing for greater order fulfillment [30][31] Market Dynamics - **Geographic Exposure**: Minimal exposure to geopolitical risks in the Middle East, with only 1% of sales from the region [11][12] - **Order Trends**: Anticipated strong order growth in data centers, with a backlog of $1 billion for 2026 [30][31] Challenges and Risks - **Market Conditions**: Facing tough comparisons from previous years, particularly in residential and light commercial sectors, with expectations of a 20% decline in the first half of the year [14][62] - **Economic Factors**: Concerns over existing home sales, new home construction, and consumer confidence impacting overall market performance [72] Strategic Initiatives - **Digitalization**: Emphasis on digital tools to enhance customer relationships and service efficiency [5][7] - **Partnerships**: Collaborations with Google and Tesla for energy storage solutions, aiming to influence local policy and expand market reach [79][80] Future Outlook - **Growth Projections**: Anticipated growth in the second half of 2026, driven by data center shipments and new product launches [58][60] - **Market Positioning**: Carrier aims to outperform industry growth rates through strategic investments in technology and product development [79][80] Additional Insights - **Ductless Market**: Significant growth in the ductless segment, with market share increasing to nearly 20% in the U.S. [84][100] - **Liquid Cooling**: Expected to see growth in liquid cooling revenue, although currently projected to be less than $100 million in 2026 [38][41] This summary encapsulates the key points discussed during Carrier's Q1 2026 earnings call, highlighting the company's strategic focus, financial performance, market dynamics, and future outlook.

Summary of Ardent Health Conference Call Company Overview - **Company**: Ardent Health (NYSE: ARDT) - **Industry**: Healthcare Services - **Operations**: 30 acute care hospitals and over 280 sites of care across 8 mid-sized markets - **Growth Strategy**: Joint venture growth strategy Key Performance Drivers and Challenges - **2025 Performance**: - First full year as a public company with significant growth in admissions, surgical procedures, adjusted admissions, and emergency room visits, outperforming peers [4][5] - Achieved EBITDA of $545 million in 2025 [15] - Implemented a tripartite growth strategy focusing on margin growth, outpatient footprint expansion, and selective market growth [5][8] - **Challenges**: - Industry-wide payer headwinds, including increased denials and underpayments, particularly in the second half of 2025 [6][7] - Medical malpractice issues in New Mexico affecting operations [7] - Anticipated $35 million headwind from the lack of renewal of exchange subsidies [9][10] Financial Guidance for 2026 - **Core Growth Rate**: Projected at 4% [9] - **EBITDA Guidance**: Midpoint of $510 million for 2026, with headwinds quantified at $50 million from elevated denials and $18-20 million from short-term incentive funding [15][16] - **IMPACT Program**: Expected to provide a $55 million benefit, up from $40 million, focusing on operational efficiencies and margin enhancements [27][31] Operational Initiatives - **Labor Management**: - Achieved a contract labor cost of 2.4% of salaries, wages, and benefits, the lowest since pre-pandemic levels [30] - Focus on precision staffing and controlling attrition rates [29] - **Technology Investments**: - Implementation of AI and machine learning to improve coding and documentation accuracy [31][41] - Use of Ambient scribes and patient wearables to enhance clinical workflows and patient care [38][40] Outpatient and Joint Venture Strategy - **Outpatient Growth**: - Acquired over 20 urgent care centers, with 45% of patients being new to Ardent, leading to downstream care within the network [50][51] - Plans to expand into ambulatory surgery centers and outpatient imaging [51][52] - **Joint Venture Development**: - Engaging in 10-12 academic joint venture discussions, focusing on disciplined growth and leveraging partnerships for market expansion [56][58] Exchange Market Dynamics - **Enrollment Trends**: - Preliminary growth in enrollment in states like New Mexico (up 14%) despite challenges with premium payments [62] - Concerns over potential recoupment of claims due to non-payment of premiums during the grace period [63][64] Conclusion - Ardent Health is positioned for selective growth in 2026, focusing on operational efficiencies, outpatient expansion, and strategic joint ventures while navigating industry challenges and market dynamics. The company remains cautiously optimistic about its financial outlook and operational improvements.

Summary of Annexon Biosciences Investor Day on Vonoprumat for Geographic Atrophy Company Overview - **Company**: Annexon Biosciences (NasdaqGS:ANNX) - **Focus**: Development of vonoprumat for the treatment of geographic atrophy (GA), a leading cause of blindness affecting approximately 8 million people globally [12][14] - **Mission**: To create targeted immunotherapies to treat neuroinflammation by stopping harmful C1q-driven inflammation [3][4] Key Points Discussed Scientific and Clinical Underpinnings - **C1q's Role**: C1q is crucial in the classical pathway that drives vision loss in GA. It accumulates on synapses during aging and neurodegenerative diseases, leading to the removal of functioning synapses [5][20] - **Phase II Study**: The ARCHER trial demonstrated structural and functional benefits from blocking C1q inflammation, providing a foundation for the upcoming Phase III program [2][9] Clinical Programs and Pipeline - **GBS Program**: The most advanced program, showing a 90% improvement in patients by week 1 in a Phase III trial, with plans for regulatory approval in Europe and the U.S. [9] - **GA Program**: Targeting C1q to preserve synapses and neurons, with Phase III data expected in Q4 of this year [9][12] Market Opportunity - **Unmet Need**: GA represents the largest unmet need in retina, with no approved vision-preserving therapies currently available [14][15] - **Patient Concerns**: Patients prioritize maintaining independence and the ability to perform daily activities, with vision loss being a significant concern [17][18] Mechanism of Action - **Differentiation from Other Therapies**: Vonoprumat's mechanism of action is distinct from C3 and C5 inhibitors, as it targets C1q to prevent neuroinflammatory damage before it leads to irreversible vision loss [10][38] - **Therapeutic Strategy**: By inhibiting C1q, the drug aims to protect photoreceptors and maintain visual acuity, addressing the disease at an earlier stage [37][38] Clinical Trial Insights - **Phase II ARCHER Trial Design**: Included 270 patients with both foveal and non-foveal GA lesions, focusing on GA growth as the primary endpoint [44][46] - **Anatomic Outcomes**: The primary endpoint of slowing GA lesion growth was not met in the first six months, but there was a potential signal in the second six months, suggesting a longer trial may yield more significant results [48][49] - **Functional Outcomes**: The trial showed a 73% reduction in the risk of 15-letter visual acuity loss with monthly dosing, indicating dose-dependent protection [56][58] Imaging and Biomarkers - **OCT vs. Fundus Autofluorescence**: OCT imaging of the ellipsoid zone is emerging as a critical biomarker for assessing photoreceptor health and visual function, potentially replacing fundus autofluorescence in future trials [50][55] Additional Important Insights - **Patient Population**: The trial included patients with advanced age-related macular degeneration (AMD), highlighting the need for effective therapies in this demographic [15][46] - **Future Directions**: The company plans to provide further updates on the market opportunity for GA and the potential impact of vonoprumat later in the year [13][12] This summary encapsulates the key discussions and insights from the Annexon Biosciences Investor Day, focusing on the development of vonoprumat for geographic atrophy and its implications for patients and the market.